Document:

Exhibit
10.6

 

AMENDMENT
TO CONSULTING aGREEMENT

 

This
Third Amendment (the “Third Amendment”) by and between RenovoRx, Inc. (the “Company”) and Ramtin
Agah (“Consultant”) (together, the “Parties”) amends the Consulting Agreement by
and between the Parties dated January 1, 2018 (“Consulting Agreement”), as amended by the Second Amendment
to Consulting Agreement, effective August 1, 2019 (the “Second Amendment” and together with the Consulting
Agreement, the “Agreement”). This Amendment is entered into as of November 11, 2021 (“Amendment
Effective Date”).

 

The
Parties desire to amend on the terms of the Agreement on the terms set forth herein.

 

1.
Amendment to Section 6. Section 6 of the Agreement is hereby amended and restated in its entirety as follows:

 

Obligation
to Keep Company Informed. During the period of this Agreement, Consultant shall promptly disclose to the Company fully and in
writing all Inventions in the Field authored, conceived or reduced to practice by Consultant, either alone or jointly with others.

 

2.
Amendment to Section 8.2. Section 8.2 of the Agreement is hereby amended and restated in its entirety as follows:

 

Conflicting
Obligations. Consultant represents and warrants that Consultant has no agreements, relationships, or commitments to any other
person or entity that conflict with the provisions of this Agreement, Consultant’s obligations to the Company under this Agreement,
and/or Consultant’s ability to perform Consultant’s services to the Company. Consultant will not enter into any such conflicting
agreement during the term of this Agreement. Consultant agrees to notify Company if he enters into any agreement with a third party that
relates to the research, design, development, transfer of intellectual property rights, commercializing and/or marketing of any product
or technology relating to the attempted treatment or enhanced treatment of solid tumors by any endovascular or catheter-based approach,
including by means of delivery of any therapeutic materials to solid tumors, and all related devices, accessories, products, kits or
services (collectively, the “Field”). Consultant shall not use the funding, resources and facilities of any
other third party, without the prior written consent of the Company, to perform services hereunder and shall not perform the services
hereunder in any manner that would give any third party rights or access to the product of such services. The services performed hereunder
will not be conducted on time that is required to be devoted to any other third party. Without limiting the foregoing, Consultant agrees
to use his or her best efforts (A) to segregate Consultant’s services performed under this Agreement from Consultant’s work
done for any third party so as to minimize any questions of rights under any inventions, (B) to notify the Company if at any time the
Consultant believes that such questions may result from Consultant’s performance under this Agreement and (C) to assist the Company
in fairly resolving any questions in this regard which may arise.

 

2.
Deletion of Section 8.3.  Section 8.3 of the Agreement is hereby entirely deleted from the Agreement.

 

3.
Amendment to 9.1. Section 9.1 of the Agreement is amended as restated in its entirety as follows:

 

Term.
The term of this Agreement began on the Effective Date of this Agreement and will continue until the earlier of (i) final completion
of Consultant’s services to the Company under this Agreement or (ii) termination as provided in Section 9.2 of this Agreement.

 

    	 

     

    

 

4.
Amendment of Section 10.5. Section 10.5 of the Agreement is hereby amended and restated in its entirety as follows:

 

Arbitration
and Equitable Relief.

 

A.
Arbitration. In consideration of Consultant’s consulting relationship with
THE Company, its promise to arbitrate all disputes related to Consultant’s consulting relationship with the Company and Consultant’s
receipt of compensation and other CONSIDERATION PROVIDED to Consultant by the Company, at present and in the future, Consultant agrees
that any and all controversies, claims, or disputes that consultant may have with the company (including any Company employee, officer,
director, trustee, or benefit plan of the Company, in their capacity as such or otherwise), arising out of, relating to, or resulting
from Consultant’s consulting or other relationship with the Company or the termination of Consultant’s consulting or other
relationship with the Company, including any breach of this Agreement, shall be subject to binding arbitration pursuant to the federal
arbitration Act (9 U.S.C. sec. 1 ET SEQ.) (THE “FAA”). THE FAA’S SUBSTANTIVE AND PROCEDURAL PROVISIONS
SHALL EXCLUSIVELY GOVERN AND APPLY WITH FULL FORCE AND EFFECT TO THIS ARBITRATION AGREEMENT, INCLUDING ITS ENFORCEMENT, AND ANY STATE
COURT OF COMPETENT JURISDICTION SHALL COMPEL ARBITRATION IN THE SAME MANNER AS A FEDERAL COURT UNDER THE FAA. CONSULTANT FURTHER AGREES
THAT, TO THE FULLEST EXTENT PERMITTED BY LAW, CONSULTANT MAY BRING ANY ARBITRATION PROCEEDING ONLY IN CONSULTANT’S INDIVIDUAL CAPACITY,
AND NOT AS A PLAINTIFF, REPRESENTATIVE, OR CLASS MEMBER IN ANY PURPORTED CLASS, COLLECTIVE, OR REPRESENTATIVE LAWSUIT OR PROCEEDING.
CONSULTANT understands, HOWEVER, that nothing in this agreement prevents consultant from BRINGing A representative lawsuit or PROCEEDING
AS permitted by the california labor code’s PRIVATE ATTORNEYs GENERAL act of 2004. TO THE FULLEST EXTENT PERMITTED BY LAW, CONSULTANT
AGREES TO ARBITRATE any AND ALL COMMON LAW AND/OR statutory claims under LOCAL, state, or federal law, including, but not limited to,
claims under THE California Labor Code, CLAIMS RELATING TO EMPLOYMENT OR INDEPENDENT CONTRACTOR STATUS, claims relating to compensation
(cash, equity, or otherwise), claims relating to CLASSIFICATION, AND RELATIONSHIP WITH THE COMPANY, AND claims of BREACH OF CONTRACT,
to the fullest extent permitted BY LAW. CONSULTANT ALSO AGREES TO ARBITRATE ANY AND ALL DISPUTES ARISING OUT OF OR RELATING TO THE INTERPRETATION
OR APPLICATION OF THIS AGREEMENT TO ARBITRATE, BUT NOT DISPUTES ABOUT THE ENFORCEABILITY, REVOCABILITY OR VALIDITY OF THIS AGREEMENT
TO ARBITRATE OR THE CLASS, COLLECTIVE AND REPRESENTATIVE PROCEEDING WAIVER HEREIN. WITH RESPECT TO ALL SUCH CLAIMS AND DISPUTES THAT
CONSULTANT AGREEs TO ARBITRATE, CONSULTANT HEREBY EXPRESSLY AGREES TO WAIVE, AND DOES WAIVE, ANY RIGHT TO A TRIAL BY JURY. Consultant
further understands that this Agreement to arbitrate also applies to any disputes that the Company may have with Consultant. CONSULTANT
UNDERSTANDS THAT NOTHING IN THIS AGREEMENT REQUIRES CONSULTANT TO ARBITRATE CLAIMS THAT CANNOT BE ARBITRATED UNDER THE SARBANES-OXLEY
ACT or other law that expressly prohibits arbitration of a claim notwithstanding the application of the faa.

 

B.
Administration of Arbitration. Consultant agrees that any arbitration will be administered
by JAMS pursuant to its EMPLOYMENT Arbitration Rules & Procedures (the “JAMS Rules”), WHICH ARE AVAILABLE
AT http://www.jamsadr.com/rules-employment-arbitration/. IF THE JAMS RULES CANNOT BE ENFORCED AS TO THE ARBITRATION, THEN THE
PARTIES AGREE THAT THEY WILL ARBITRATE THIS DISPUTE UTILIZING JAMS COMPREHENSIVE ARBITRATION RULES AND PROCEDURES OR SUCH RULES
AS THE ARBITRATOR MAY DEEM MOST APPROPRIATE FOR THE DISPUTE. CONSULTANT AGREES THAT THE USE OF
THE JAMS RULES DOES NOT CHANGE CONSULTANT’S CLASSIFICATION TO THAT OF AN EMPLOYEE. TO THE CONTRARY, CONSULTANT REAFFIRMS THAT CONSULTANT
IS AN INDEPENDENT CONTRACTOR. Consultant agrees that the arbitrator shall have the power to decide any motions brought by any party to
the arbitration, including motions for summary judgment and/or adjudication and motions to dismiss and demurrers APPLYING THE STANDARDS
for such motions SET FORTH UNDER THE CALIFORNIA CODE OF CIVIL PROCEDURE. Consultant agrees that the arbitrator shall issue a written
decision on the merits. CONSULTANT ALSO AGREES THAT THE ARBITRATOR SHALL HAVE THE POWER TO AWARD ANY REMEDIES AVAILABLE UNDER APPLICABLE
LAW, AND THAT THE ARBITRATOR MAY AWARD ATTORNEYS’ FEES AND COSTS TO THE PREVAILING PARTY, WHERE PERMITTED BY APPLICABLE LAW. CONSULTANT
AGREES that the decree or award rendered by the arbitrator may be entered as a final and binding judgment in any court having jurisdiction
thereof. CONSULTANT UNDERSTANDS THAT THE COMPANY WILL PAY FOR ANY ADMINISTRATIVE OR HEARING FEES CHARGED BY THE ARBITRATOR OR JAMS, EXCEPT
THAT CONSULTANT SHALL PAY ANY FILING FEES ASSOCIATED WITH ANY ARBITRATION THAT CONSULTANT INITIATES, BUT ONLY SO MUCH OF THE FILING FEES
AS CONSULTANT WOULD HAVE INSTEAD PAID HAD CONSULTANT FILED A COMPLAINT IN A COURT OF LAW THAT WOULD HAVE HAD JURISDICTION OVER SUCH COMPLAINT.
SUBJECT TO THE FAA’S EXCLUSIVE APPLICABILITY TO THE ENFORCEMENT OF THIS AGREEMENT TO ARBITRATE,
Consultant agrees that the arbitrator shall administer and conduct any arbitration HEARING OR PROCEEDING APPLYING CALIFORNIA SUBSTANTIVE
AND DECISIONAL LAW AND THE California Code of Civil Procedure, INCLUDING THE CALIFORNIA CIVIL DISCOVERY ACT. Consultant agrees that any
arbitration under this agreement shall be conducted in SANTA CLARA COUNTY, california.

 

    	Page 2 of 5

     

    

 

C.
Remedy. FOR PURPOSES OF SEEKING PROVISIONAL REMEDIES ONLY, CONSULTANT AGREES
THAT THE COMPANY AND CONSULTANT SHALL BE ENTITLED TO PURSUE ANY PROVISIONAL REMEDY PERMITTED BY THE CALIFORNIA ARBITRATION ACT (CALIFORNIA
CODE CIV. PROC. § 1281.8), OR OTHERWISE PROVIDED BY THIS AGREEMENT. EXCEPT FOR SUCH PROVISIONAL RELIEF, CONSULTANT AGREES THAT ANY
RELIEF OTHERWISE AVAILABLE TO THE COMPANY OR CONSULTANT UNDER APPLICABLE LAW SHALL BE PURSUED SOLELY AND EXCLUSIVELY IN ARBITRATION PURSUANT
TO THE TERMS OF THIS AGREEMENT.

 

D.
Administrative Relief. Consultant
understands that this Agreement does not prohibit Consultant from pursuing AN Administrative claim with A local, state or federal administrative
BODY OR GOVERNMENT AGENCY such as the Department of Fair Employment and Housing, the Equal Employment Opportunity Commission, the National
Labor Relations Board, THE SECURITIES AND EXCHANGE COMMISSION, or the workers’ compensation board. this agreement does, however,
preclUde consultant from bringing any alleged wage claims with the Department of labor standards enforcement. Likewise, This Agreement
does preclude Consultant from pursuing A court action regarding any SUCH CLAIM, except as permitted by law. 

 

E.
Voluntary Nature of Agreement. Consultant
acknowledges and agrees that CONSULTANT is executing this Agreement voluntarily and without any duress or undue influence by the Company
or anyone else. Consultant further acknowledges and agrees that CONSULTANT has carefully read this Agreement and that Consultant has
asked any questions needed for Consultant to understand the terms, consequences and binding effect of this Agreement and fully understand
it, including that Consultant is waiving CONSULTANT’S right to a jury trial. Consultant agrees that CONSULTANT has
been provided an opportunity to seek the advice of an attorney of Consultant’s choice before signing this Agreement.

 

5.
Insertion of Section 10.9. The following is added to the Agreement, as Section 10.9:

 

Protected
Activity Not Prohibited. Consultant understands that nothing in this Agreement limits or prohibits Consultant from filing
and/or pursuing a charge or complaint with, or otherwise communicating or cooperating with, or participating in any investigation or
proceeding that may be conducted by, any federal, state or local government agency or commission, including the Securities and Exchange
Commission (“Government Agencies”), including disclosing documents or other information as permitted by law,
without giving notice to, or receiving authorization from, the Company. In addition, nothing
in this Agreement is intended to prevent Consultant from discussing or disclosing information about
unlawful acts in the workplace, such as harassment or discrimination or any other conduct that Consultant has reason to believe is unlawful.
Consultant further understands that Consultant is not permitted to disclose the Company’s attorney-client privileged communications
or attorney work product. Pursuant to the Defend Trade Secrets Act of 2016, Consultant is notified that an individual will not be held
criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (i) is made in confidence
to a federal, state, or local government official (directly or indirectly) or to an attorney solely for the purpose of reporting
or investigating a suspected violation of law, or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding,
if (and only if) such filing is made under seal. In addition, an individual who files a lawsuit for retaliation by an employer for reporting
a suspected violation of law may disclose the trade secret to the individual’s attorney and use the trade secret information in
the court proceeding, if the individual files any document containing the trade secret under seal and does not disclose the trade secret,
except pursuant to court order.

 

    	Page 3 of 5

     

    

 

6.
Amendment to Second Amendment (which had replaced and superseded the First Amendment to the Consulting Agreement (which had previously
replaced and superseded Exhibit A of the Consulting Agreement)). The Second Amendment (as amended herein) will be known
as the Statement of Work (“SOW”). The following replaces and supersedes Section 2.1 of the Second Amendment,
and will be considered Section 2 of the SOW.

 

Section
2: Compensation 

 

2.1
Base Consulting Fee. The Company will pay Consultant a monthly consulting fee of $21,667.67 (“Base Consulting
Fee”), based on Consultant spending no less than 24 hours per week on Company matters (the “Allocated Time”).
If Consultant’s Allocated Time decreases, the Company may, in its discretion, proportionally adjust the Base Consulting Fee. Consultant
agrees that any such reduction in the Base Consulting Fee will not constitute “Good Reason” or any similar definition or
concept in any agreement, contract, or arrangement between Consultant and the Company notwithstanding any language to the contrary in
any such agreement, contract, or arrangement, nor serves as a trigger for any related benefits.

 

2.2
Bonus. Commencing in the Company’s 2022 fiscal year, Consultant will have the opportunity to earn a target annual
cash bonus equal to thirty-five percent (35%) of Consultant’s annualized Base Consulting Fee, based on achieving performance objectives
established by the Company’s Board of Directors (“Board”) or its Compensation Committee, as applicable,
in its sole discretion and payable upon achievement of those objectives, and subject to such terms and conditions, as determined by the
Board or its Compensation Committee. Unless determined otherwise by the Board or its Compensation Committee, as applicable, any such
bonus will be subject to Consultant’s continued consulting or employment relationship with the Company through and until the date
of payment, provided that service as a non-employee member of the Board will not by itself constitute a continued consulting relationship
for this purpose. Consultant’s annual bonus opportunity and the applicable terms and conditions may be adjusted from time to time
by the Board or its Compensation Committee, as applicable, in its sole discretion.

 

2.3
Section 409A. In order to help prevent adverse tax consequences to Consultant under Section 409A (as defined below) should
Consultant be or become subject to U.S. taxes, in no event will any payment under Section 2.1 or section 2.2 of this Statement of Work
be made later than the later of (1) March 15th of the calendar year following the calendar year in which such payment was
earned, or (2) the 15th day of the third (3rd) month following the end of the Company’s fiscal year in which such payment
was earned. All payments and benefits provided for under this Agreement are intended to be exempt from or otherwise comply with the requirements
of Section 409A of the Internal Revenue Code of 1986, as amended, and the regulations and guidance thereunder (together, “Section
409A”) so that none of the payments and benefits to be provided hereunder will be subject to the additional tax imposed
under Section 409A, and any ambiguities or ambiguous terms herein will be interpreted to be exempt or so comply. Each payment and benefit
payable under this Agreement is intended to constitute a separate payment for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations.
In no event will the Company have any responsibility, liability or obligation to reimburse, indemnify or hold harmless Consultant or
any other person for any taxes penalties or interest that may be imposed, or other costs that may be incurred, by Consultant or any other
person as a result of Section 409A.

 

7.
Insertion to Second Amendment. The following is added as Section 3 of the Second Amendment (the SOW).

 

Section
3: Reimbursement 

 

The
Company will reimburse Consultant, in accordance with Company policy, for all reasonable expenses incurred by Consultant in performing
the services pursuant to this Agreement, if Consultant receives written consent from an authorized agent of the Company prior to incurring
such expenses and submits receipts for such expenses to the Company in accordance with Company policy.

 

    	Page 4 of 5

     

    

 

8.
Miscellaneous

 

A.
Full Force and Effect. To the extent not expressly amended hereby, the Agreement shall remain in full force and effect.

 

B.
Entire Agreement. This Third Amendment, together with the Agreement, constitutes the full and entire understanding and
agreement between Company and Consultant with respect to the subjects hereof and thereof.

 

C.
No Oral Modification. No modification of or amendment to this Third Amendment (or the Agreement) will be effective
unless in a writing signed by Consultant and an authorized signatory of the Company.

 

	Company 	Consultant: 
	 	 	 	 
	By:	/s/ Shaun R. Bagai	By:	/s/ Ramtin Agah
	 	 	 	 
	Name:	Shaun R. Bagai       	Name:	 Ramtin Agah, MD     
	 	 	 	 
	Title:	Chief Executive Officer        	Title:	CMO
	 	 	 	 
	Date:	November 11, 2021	Date:	November 11, 2021

 

    	Page 5 of 5Exhibit
10.7

 

RenovoRX,
INC.

 

CHANGE
IN CONTROL AND SEVERANCE AGREEMENT

 

This
Change in Control and Severance Agreement (the “Agreement”) is made by and between RenovoRx, Inc., a Delaware corporation
(the “Company”), and Shaun R. Bagai (“Executive”), effective as of the Effective Date, as defined
in Section 7 below.

 

This
Agreement provides certain protections to Executive in connection with an involuntary termination of Executive’s employment with
the Company under the circumstances described in this Agreement, including in connection with a change in control of the Company. Certain
capitalized terms used in this Agreement are defined in Section 7 below.

 

The
Company and Executive agree as follows:

 

1.
Term of Agreement. This Agreement will continue indefinitely until terminated by written consent of the parties hereto, or if
earlier, upon the date that all of the obligations of the parties hereto with respect to this Agreement have been satisfied.

 

2.
At-Will Employment. The Company and Executive acknowledge that Executive’s employment is and will continue to be at-will,
as defined under applicable law. No payments, benefits, or provisions under this Agreement will confer upon Executive any right to continue
Executive’s employment with the Company, nor will they interfere with or limit in any way the right of the Company or Executive
to terminate such relationship at any time, with or without cause, to the extent permitted by applicable laws.

 

3.
Severance Benefits.

 

(a)
Qualifying Termination Outside of the Change in Control Period. In the event of a Qualifying Termination that occurs other than
during the Change in Control Period, Executive will receive the following payments and benefits from the Company, subject to the requirements
of this Agreement:

 

(i)
Base Compensation Severance. A single, lump sum, cash payment equal to one-hundred percent (100%) of Executive’s Annual
Base Compensation.

 

(ii)
Bonus Severance. A single, lump sum, cash payment equal to the product of (i) the Executive’s Target Bonus, if any, that
the Executive would have earned for the entire fiscal year in which the Qualifying Termination occurs; and (ii) a fraction, the numerator
of which is the number of days the Executive was employed by the Company during the fiscal year in which the Qualifying Termination occurs
and the denominator of which is the number of days in such fiscal year.

 

(iii)
COBRA Severance. Subject to Executive timely electing continuation coverage under the Consolidated Omnibus Budget Reconciliation
Act of 1985, as amended (“COBRA”) and further subject to Section 5(c), Executive will receive Company-paid group health,
dental and vision coverage for Executive and any of Executive’s eligible dependents, as applicable (the “COBRA Severance”),
following the Qualifying Termination until the earliest of: (A) twelve (12) months following the date of the Qualifying Termination,
(B) the date on which Executive and Executive’s eligible dependents (as applicable) become covered under similar plans, or (C)
the expiration of Executive’s (and any of Executive’s eligible dependents’, as applicable) eligibility for continuation
coverage under COBRA.

 

    	 

     

    

 

(b)
Qualifying Termination During the Change in Control Period. In the event of a Qualifying Termination that occurs during the Change
in Control Period, Executive will receive the following payments and benefits from the Company, subject to the requirements of this Agreement:

 

(i)
Base Compensation Severance. A single, lump sum, cash payment equal to one-hundred and fifty percent (150%) of Executive’s
Annual Base Compensation.

 

(ii)
COBRA Severance. Subject to Executive timely electing continuation coverage under COBRA and further subject to Section 5(c), Executive
will receive COBRA Severance until the earliest of: (A) eighteen (18) months following the date of the Qualifying Termination, (B) the
date on which Executive and Executive’s eligible dependents (as applicable) become covered under similar plans, or (C) the expiration
of Executive’s (and any of Executive’s eligible dependents, as applicable) eligibility for continuation coverage under COBRA.

 

(iii)
Vesting Acceleration of Service-based Equity Awards. Notwithstanding the terms of the Company equity plan or plans under which
the Executive’s Awards are granted or any applicable award agreements, vesting acceleration of one hundred percent (100%) of any
Equity Awards that are outstanding and unvested as of the date of the Qualifying Termination.

 

(c)
Termination Other Than a Qualifying Termination. If the termination of Executive’s employment does not constitute a Qualifying
Termination, then Executive will not be entitled to receive any severance or other benefits in connection with such termination except
for those, if any, as may then be established under the Company’s then existing severance and benefits plans or programs.

 

(d)
Non-duplication of Payment or Benefits. Notwithstanding any provision of this Agreement to the contrary, if Executive is entitled
to any cash severance, continued health coverage benefits, vesting acceleration of any Awards, or other severance or separation benefits
similar to those provided under this Agreement, by operation of applicable law or under a plan, policy, contract, or arrangement sponsored
by or to which the Company is a party other than this Agreement (“Other Benefits”), then the corresponding severance
payments and benefits under this Agreement will be reduced by the amount of Other Benefits paid or provided to Executive.

 

(e)
Death of Executive. In the event of Executive’s death before all payments or benefits Executive is entitled to receive under
this Agreement have been provided, the unpaid amounts will be provided to Executive’s designated beneficiary, if living, or otherwise
to Executive’s personal representative in accordance with the terms of this Agreement.

 

    	-2-

     

    

 

4.
Accrued Compensation. On any termination of Executive’s employment with the Company, Executive will be entitled to receive
all accrued but unpaid vacation, expense reimbursements, wages, and other benefits due to Executive under any Company-provided plans,
policies, and arrangements.

 

5.
Conditions to Receipt of Severance.

 

(a)
Separation Agreement and Release of Claims. Executive’s receipt of any severance payments or benefits upon a Qualifying
Termination under Section 3 is subject to Executive signing and not revoking the Company’s then standard separation agreement and
release of claims with the Company (the “Release”), which must become effective and irrevocable no later than the
sixtieth (60th) day following the date of the Qualifying Termination (the “Release Deadline Date”). If
the Release does not become effective and irrevocable by the Release Deadline Date, Executive will forfeit any right to severance payments
or benefits under Section 3.

 

(b)
Payment Timing. Any lump sum cash severance payments under Section 3 relating to base compensation severance and any bonus severance
will be provided to Executive on the first regularly scheduled payroll date of the Company following the date the Release becomes effective
and irrevocable, subject to any delay required by Section 5(d) below. Any Equity Awards that are restricted stock units, performance
shares, performance units, and/or similar full value awards (“Full Value Awards”) that accelerate vesting under Section
3(b)(iii) will be settled, subject to any delay required by Section 5(d) below (or the terms of the Full Value Award agreement or other
Company plan, policy, or arrangement governing the settlement timing of the Full Value Award to the extent such terms specifically require
any such delay in order to comply with the requirements of Section 409A, as applicable), on a date within ten (10) days following the
date the Release becomes effective and irrevocable.

 

(c)
COBRA Severance Limitations. If the Company determines in its sole discretion that it cannot provide the COBRA Severance without
potentially violating, or being subject to an excise tax under, applicable law (including, without limitation, Section 2716 of the Public
Health Service Act), then in lieu of such COBRA Severance, subject to any delay required by Section 5(d) below and except as provided
by the last sentence of this Section 5(c), the Company will provide to Executive a taxable monthly payment payable on the last day of
a given month (provided that no such payments will be made prior to the effectiveness of the Release, and any such payments delayed as
a result will be paid, subject to any delay required by Section 5(d) below, in a lump sum on the first regularly scheduled payroll date
of the Company following the date the Release becomes effective and irrevocable), in an amount equal to the monthly COBRA premium that
Executive would be required to pay to continue Executive’s group health coverage in effect on the date of the Qualifying Termination
(which amount will be based on the premium rates applicable for the first month of COBRA Severance for Executive and any eligible dependents
of Executive) (each, a “COBRA Replacement Payment”), which COBRA Replacement Payments will be made regardless of whether
Executive elects COBRA continuation coverage and will end on the earlier of (i) the date upon which Executive obtains other employment,
or (ii) the date the Company has paid an amount totaling the number of COBRA Replacement Payments equal to the number of months in the
applicable COBRA Severance period set forth in clause (A) of Section 3(a)(iii) or Section 3(b)(ii), as applicable. For the avoidance
of doubt, the COBRA Replacement Payments may be used for any purpose, including, but not limited to continuation coverage under COBRA,
and will be subject to any applicable withholdings. Notwithstanding anything to the contrary under this Agreement, if the Company determines
in its sole discretion at any time that it cannot provide the COBRA Replacement Payments without violating applicable law (including,
without limitation, Section 2716 of the Public Health Service Act), Executive will not receive the COBRA Replacement Payments or any
further COBRA Severance.

 

    	-3-

     

    

 

(d)
Section 409A. The Company intends that all payments and benefits provided under this Agreement or otherwise are exempt from, or
comply with, the requirements of Section 409A so that none of the payments or benefits will be subject to the additional tax imposed
under Section 409A, and any ambiguities and ambiguous terms in this Agreement will be interpreted in accordance with this intent. No
payments or benefits to be provided to Executive, if any, under this Agreement or otherwise, when considered together with any other
severance payments or separation benefits that are considered deferred compensation under Section 409A (together, the “Deferred
Payments”) will be paid or otherwise provided until Executive has a “separation from service” within the meaning
of Section 409A. To the extent required to be exempt from or comply with Section 409A, references to the termination of Executive’s
employment or similar phrases used in this Agreement will mean Executive’s “separation from service” within the meaning
of Section 409A.

 

(i)
Any payments or benefits paid or provided under this Agreement that satisfy the requirements of the “short-term deferral”
rule under Treasury Regulations Section 1.409A-1(b)(4), or that qualify as payments made as a result of an involuntary separation from
service under Treasury Regulations Section 1.409A-1(b)(9)(iii) that is within the limit set forth thereunder, will not constitute Deferred
Payments for purposes of this Section 5(d).

 

(ii)
Notwithstanding any provisions to the contrary in this Agreement, if Executive is a “specified employee” within the meaning
of Section 409A at the time of Executive’s separation from service (other than due to death), then any payments or benefits under
this Agreement that constitute Deferred Payments payable within the first six (6) months after Executive’s separation from service
instead will be payable on the date six (6) months and one (1) day after Executive’s separation from service; provided that in
the event of Executive’s death within such six (6) month period, any payments delayed by this subsection (ii) will be paid to Executive
in a lump sum as soon as administratively practicable after the date of Executive’s death. To the extent that Executive is not
a specified employee but Executive’s Qualifying Termination occurs at a time during the year whereby the Release Deadline Date
will occur in the year immediately following the year in which the Qualifying Termination occurs, then any payments or benefits under
this Agreement that constitute Deferred Payments that otherwise would be payable prior to the Release Deadline Date instead will be paid
on the first regularly scheduled payroll date of the Company following the Release Deadline Date.

 

(iii)
The Company reserves the right to amend this Agreement as it considers necessary or advisable, in its sole discretion and without the
consent of Executive or any other individual, to comply with any provision required to avoid the imposition of the additional tax imposed
under Section 409A or to otherwise avoid income recognition under Section 409A prior to the actual payment of any benefits or imposition
of any additional tax. Each payment, installment, and benefit payable under this Agreement is intended to constitute a separate payment
for purposes of Treasury Regulations Section 1.409A-2(b)(2). In no event will Executive have any discretion to choose Executive’s
taxable year in which any payments or benefits are provided under this Agreement. In no event will the Company or any parent, subsidiary
or other affiliate of the Company have any responsibility, liability or obligation to reimburse, indemnify or hold harmless Executive
for any taxes, penalties or interest that may be imposed, or other costs that may be incurred, as a result of Section 409A.

 

    	-4-

     

    

 

6.
Limitation on Payments.

 

(a)
Reduction of Severance Benefits. If any payment or benefit that Executive would receive from the Company or any other party whether
in connection with the provisions in this Agreement or otherwise (the “Payments”) would (i) constitute a “parachute
payment” within the meaning of Section 280G of the Code and (ii) but for this sentence, be subject to the excise tax imposed by
Section 4999 of the Code (the “Excise Tax”), then the Payments will be either delivered in full, or delivered as to
such lesser extent that would result in no portion of the Payments being subject to the Excise Tax, whichever of the foregoing amounts,
taking into account the applicable federal, state and local income taxes and the Excise Tax, results in Executive’s receipt, on
an after-tax basis, of the greatest amount of Payments, notwithstanding that all or some of the Payments may be subject to the Excise
Tax. If a reduction in Payments is made in accordance with the immediately preceding sentence, the reduction will occur, with respect
to the Payments considered parachute payments within the meaning of Code Section 280G, in the following order: (A) reduction of cash
payments in reverse chronological order (that is, the cash payment owed on the latest date following the occurrence of the event triggering
the Excise Tax will be the first cash payment to be reduced); (B) cancellation of equity awards that were granted “contingent on
a change in ownership or control” within the meaning of Section 280G of the Code in the reverse order of date of grant of the equity
awards (that is, the most recently granted equity awards will be cancelled first); (C) reduction of the accelerated vesting of equity
awards in the reverse order of date of grant of the equity awards (that is, the vesting of the most recently granted equity awards will
be cancelled first); and (D) reduction of employee benefits in reverse chronological order (that is, the benefit owed on the latest date
following the occurrence of the event triggering the Excise Tax will be the first benefit to be reduced). In no event will Executive
have any discretion with respect to the ordering of Payment reductions. Executive will be solely responsible for the payment of all personal
tax liability that is incurred as a result of the payments and benefits received under this Agreement, and neither the Company nor any
parent, subsidiary or other affiliate of the Company have any responsibility, liability or obligation to reimburse, indemnify or hold
harmless Executive for any of those payments of personal tax liability.

 

(b)
Determination of Excise Tax Liability. Unless the Company and Executive otherwise agree in writing, any determinations required
under this Section 6 will be made in writing by a nationally recognized accounting or valuation firm (the “Firm”)
selected by the Company, whose determinations will be conclusive and binding upon Executive and the Company for all purposes. For purposes
of making the calculations required by this Section 6, the Firm may make reasonable assumptions and approximations concerning applicable
taxes and may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code. The Company
and Executive will furnish to the Firm such information and documents as the Firm reasonably may request in order to make determinations
under this Section 6. The Company will bear the costs and make all payments required to be made to the Firm for the Firm’s services
that are rendered in connection with any calculations contemplated by this Section 6. The Company will have no liability to Executive
for the determinations of the Firm.

 

    	-5-

     

    

 

7.
Definitions. The following terms referred to in this Agreement will have the following meanings:

 

(a)
“Annual Base Compensation “ means Executive’s annual base salary in effect immediately prior to Executive’s
Qualifying Termination (or, if the termination is due to a resignation for Good Reason based on a material reduction in Executive’s
annual base salary, then Executive’s annual base salary in effect immediately prior to the reduction) or, if Executive’s
Qualifying Termination occurs during the Change in Control Period and the amount is greater, Executive’s annual base salary in
effect immediately prior to the Change in Control.

 

(b)
“Award” means stock options and other equity awards covering shares of Company common stock granted to Executive.

 

(c)
“Board” means the Company’s Board of Directors.

 

(d)
“Cause” means Executive’s: (i) dishonesty of a material nature; (ii) theft or embezzlement of Company funds
or assets; (iii) being convicted of, or guilty plea or no contest plea to, a felony charge or any misdemeanor involving moral turpitude,
or the entry of a consent decree with any governmental body; (iv) noncompliance in any material respect with any U.S. or non-U.S. laws
or regulations; (v) violation of any express direction or any rule, regulation or policy established by the Company or the Board; (vi)
material breach of this Agreement or the Confidentiality Agreement; (vii) breach of any fiduciary duty to the Company; (viii) gross incompetence,
neglect, or misconduct in the performance of Executive’s duties; or (ix) repeated failure to perform Executive’s duties and
responsibilities for the Company or follow the reasonable and lawful instructions of the Company.

 

(e)
“Change in Control” means the first occurrence of any of the following events on or after the Effective Date:

 

(i)
Change in Ownership of the Company. A change in the ownership of the Company which occurs on the date that any one person, or
more than one person acting as a group (“Person”), acquires ownership of the stock of the Company that, together with
the stock held by such Person, constitutes more than fifty percent (50%) of the total voting power of the stock of the Company; provided,
however, that for purposes of this subsection, the acquisition of additional stock by any one Person, who is considered to own more than
fifty percent (50%) of the total voting power of the stock of the Company will not be considered a Change in Control; provided, further,
that any change in the ownership of the stock of the Company as a result of a private financing of the Company that is approved by the
Board also will not be considered a Change in Control. Further, if the stockholders of the Company immediately before such change in
ownership continue to retain immediately after the change in ownership, in substantially the same proportions as their ownership of shares
of the Company’s voting stock immediately prior to the change in ownership, direct or indirect beneficial ownership of fifty percent
(50%) or more of the total voting power of the stock of the Company or of the ultimate parent entity of the Company, such event shall
not be considered a Change in Control under this subsection (i). For this purpose, indirect beneficial ownership shall include, without
limitation, an interest resulting from ownership of the voting securities of one or more corporations or other business entities which
own the Company, as the case may be, either directly or through one or more subsidiary corporations or other business entities; or

 

    	-6-

     

    

 

(ii)
Change in Effective Control of the Company. If the Company has a class of securities registered pursuant to Section 12 of the
U.S. Securities Exchange Act of 1934, as amended, a change in the effective control of the Company which occurs on the date that a majority
of members of the Board is replaced during any twelve (12) month period by Directors whose appointment or election is not endorsed by
a majority of the members of the Board prior to the date of the appointment or election. For purposes of this subsection (ii), if any
Person is considered to be in effective control of the Company, the acquisition of additional control of the Company by the same Person
will not be considered a Change in Control; or

 

(iii)
Change in Ownership of a Substantial Portion of the Company’s Assets. A change in the ownership of a substantial portion
of the Company’s assets which occurs on the date that any Person acquires (or has acquired during the twelve (12) month period
ending on the date of the most recent acquisition by such Person or Persons) assets from the Company that have a total gross fair market
value equal to or more than fifty percent (50%) of the total gross fair market value of all of the assets of the Company immediately
prior to such acquisition or acquisitions; provided, however, that for purposes of this subsection (iii), the following will not constitute
a change in the ownership of a substantial portion of the Company’s assets: (A) a transfer to an entity that is controlled by the
Company’s stockholders immediately after the transfer, or (B) a transfer of assets by the Company to: (1) a stockholder of the
Company (immediately before the asset transfer) in exchange for or with respect to the Company’s stock, (2) an entity, fifty percent
(50%) or more of the total value or voting power of which is owned, directly or indirectly, by the Company, (3) a Person, that owns,
directly or indirectly, fifty percent (50%) or more of the total value or voting power of all the outstanding stock of the Company, or
(4) an entity, at least fifty percent (50%) of the total value or voting power of which is owned, directly or indirectly, by a Person
described in this subsection (iii)(B)(3). For purposes of this subsection (iii), gross fair market value means the value of the assets
of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets.

 

For
purposes of this definition, persons will be considered to be acting as a group if they are owners of a corporation that enters into
a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company.

 

Notwithstanding
the foregoing, a transaction will not be deemed a Change in Control unless the transaction qualifies as a change in control event within
the meaning of Section 409A. Further and for the avoidance of doubt, a transaction will not constitute a Change in Control if: (x) its
sole purpose is to change the jurisdiction of the Company’s incorporation, or (y) its sole purpose is to create a holding company
that will be owned in substantially the same proportions by the persons who held the Company’s securities immediately before such
transaction.

 

    	-7-

     

    

 

(f)
“Change in Control Period” means the period beginning on the date of a Change in Control and ending on (and inclusive
of) the date that is the one (1) year anniversary of a Change in Control.

 

(g)
“Code” means the Internal Revenue Code of 1986, as amended. Reference to a specific section of the Code or regulation
thereunder will include such section or regulation, any valid regulation promulgated under such section, and any comparable provision
of any future legislation or regulation amending, supplementing or superseding such section or regulation.

 

(h)
“Confidentiality Agreement” means Executive’s Employee Confidentiality, Inventions and Non-Interference Agreement
entered into with the Company dated January 1, 2016.

 

(i)
“Director” means a member of the Board.

 

(j)
“Disability” means total and permanent disability as defined in Code Section 22(e)(3).

 

(k)
“Effective Date” means November 11, 2021.

 

(l)
“Equity Awards” means Awards that, as of the date of the Qualifying Termination, are held by Executive and subject
to continued service-based vesting criteria, but not subject to the achievement of any performance-based or other similar vesting criteria.

 

(m)
“Good Reason” means Executive’s termination of Executive’s employment with the Company within thirty (30)
days following the end of the Company’s Cure Period (as defined below) as a result of the occurrence of any of the following without
Executive’s written consent: (i) a material diminution in Executive’s annual base salary; (ii) the assignment to Executive
of duties that are materially inconsistent with Executive’s duties that results in a material diminution of Executive’s duties
with the Company in effect immediately prior to such assignment; (iii) a material diminution in Executive’s authority, responsibilities,
or job title; (iv) a material change in the location of Executive’s primary place of work to a location more than thirty (30) miles
from Executive’s primary place of work immediately prior to such change and that is further from Executive’s residence; provided,
however, that Executive must provide written notice to the Company of the condition that could constitute a “Good Reason”
event within sixty (60) days following the initial existence of such condition and such condition must not have been remedied by the
Company within thirty (30) days (the “Cure Period”) of such written notice. To the extent Executive’s primary
work location is Executive’s residence due to a shelter-in-place order or similar work-from-home arrangement that applies to Executive,
Executive’s primary place of work, from which a change in location under the foregoing clause (iv) will be measured, will be considered
the Company’s office location where Executive’s employment with the Company primarily was based immediately prior to the
commencement of such shelter-in-place order or similar work-from-home arrangement.

 

(n)
“Qualifying Termination” means a termination of Executive’s employment with the Company either (i) by the Company
without Cause and other than due to Executive’s death or Disability, or (ii) by Executive for Good Reason.

 

    	-8-

     

    

 

(o)
“Section 409A” means Code Section 409A and the Treasury Regulations and guidance thereunder, and any applicable state
law equivalent, as each may be promulgated, amended or modified from time to time.

 

(p)
“Target Bonus” means Executive’s annual (or annualized, if applicable) target bonus in effect immediately prior
to Executive’s Qualifying Termination or, if Executive’s Qualifying Termination occurs during the Change in Control Period
and the amount is greater, Executive’s annual (or annualized, if applicable) target bonus in effect immediately prior to the Change
in Control.

 

8.
Successors. This Agreement will be binding upon and inure to the benefit of (a) the heirs, executors, and legal representatives
of Executive upon Executive’s death, and (b) any successor of the Company. Any such successor of the Company will be deemed substituted
for the Company under the terms of this Agreement for all purposes. For this purpose, “successor” means any person, firm,
corporation, or other business entity which at any time, whether by purchase, merger, or otherwise, directly or indirectly acquires all
or substantially all of the assets or business of the Company. None of the rights of Executive to receive any form of compensation payable
pursuant to this Agreement may be assigned or transferred except by will or the laws of descent and distribution. Any other attempted
assignment, transfer, conveyance, or other disposition of Executive’s right to compensation or other benefits will be null and
void.

 

9.
Notice.

 

(a)
General. All notices and other communications required or permitted under this Agreement will be in writing and will be effectively
given (i) upon actual delivery to the party to be notified, (ii) upon transmission by email, (iii) twenty-four (24) hours after confirmed
facsimile transmission, (iv) one (1) business day after deposit with a recognized overnight courier, or (v) three (3) business days after
deposit with the U.S. Postal Service by first class certified or registered mail, return receipt requested, postage prepaid, addressed:
(A) if to Executive, at the address Executive will have most recently furnished to the Company in writing, (B) if to the Company, at
the following address:

 

RenovoRx,
Inc.

4546
El Camino Real, Suite B1

Los
Altos, California 94022

Attention:
Chairman of the Board

 

(b)
Notice of Termination. Any termination of Executive’s employment by the Company for Cause will be communicated by a notice
of termination of Executive’s employment to Executive, and any termination by Executive for Good Reason will be communicated by
a notice of termination to the Company, in each case given in accordance with Section 9(a). The notice will indicate the specific termination
provision in this Agreement relied upon, will set forth in reasonable detail the facts and circumstances claimed to provide a basis for
termination under the provision so indicated, and will specify the termination date (which will be not more than thirty (30) days after
the later of (i) the giving of the notice or (ii) the end of any applicable cure period).

 

    	-9-

     

    

 

10.
Resignation. The termination of Executive’s employment for any reason also will constitute, without any further required
action by Executive, Executive’s voluntary resignation from all officer and/or director positions held at the Company or any of
its subsidiaries or affiliates, and at the Board’s request, Executive will execute any documents reasonably necessary to reflect
the resignations.

 

11.
Miscellaneous Provisions.

 

(a)
No Duty to Mitigate. Executive will not be required to mitigate the amount of any payment contemplated by this Agreement, nor
will any payment be reduced by any earnings that Executive may receive from any other source except as specified in Sections 3(d), 5(d)
and 6.

 

(b)
Waiver; Amendment. No provision of this Agreement will be modified, waived or discharged unless the modification, waiver or discharge
is agreed to in writing and signed by an authorized officer of the Company (other than Executive) and by Executive. No waiver by either
party of any breach of, or of compliance with, any condition or provision of this Agreement by the other party will be considered a waiver
of any other condition or provision or of the same condition or provision at another time.

 

(c)
Headings. Headings are provided herein for convenience only, and will not serve as a basis for interpretation or construction
of this Agreement.

 

(d)
Entire Agreement. This Agreement, together with the Confidentiality Agreement, Executive’s offer letter with the Company
dated November 11, 2021, and the Company’s 2021 Omnibus Equity Incentive Plan and award agreements thereunder governing Executive’s
Awards, constitutes the entire agreement of the parties and supersedes in their entirety all prior representations, understandings, undertakings
or agreements (whether oral or written and whether expressed or implied) of the parties with respect to the subject matter of this Agreement,
including without limitation, Executive’s offer letter, as amended, with the Company originally dated December 29, 2015.

 

(e)
Governing Law. This Agreement will be governed by the laws of the State of California but without regard to the conflict of law
provision. To the extent that any lawsuit is permitted with respect to any provisions under this Agreement, Executive hereby expressly
consents to the personal and exclusive jurisdiction and venue of the state and federal courts located in the State of California for
any lawsuit filed against Executive by the Company.

 

(f)
Severability. If any provision of this Agreement is or becomes or is deemed to be invalid, illegal, or unenforceable for any reason,
such invalidity, illegality, or unenforceability will not affect the remaining parts of this Agreement, and this Agreement will be construed
and enforced as if the invalid, illegal, or unenforceable provision had not been included.

 

(g)
Withholding. The Company (and any parent, subsidiary or other affiliate of the Company, as applicable) will have the right and
authority to deduct from any payments or benefits all applicable federal, state, local, and/or non-U.S. taxes or other required withholdings
and payroll deductions (“Withholdings”). Prior to the payment of any amounts or provision of any benefits under this
Agreement, the Company (and any parent, subsidiary or other affiliate of the Company, as applicable) is permitted to deduct or withhold,
or require Executive to remit to the Company, an amount sufficient to satisfy any applicable Withholdings with respect to such payments
and benefits. Neither the Company nor any parent, subsidiary or other affiliate of the Company will have any responsibility, liability
or obligation to pay Executive’s taxes arising from or relating to any payments or benefits under this Agreement.

 

(h)
Counterparts. This Agreement may be executed in counterparts, each of which will be deemed an original, but all of which together
will constitute one and the same instrument.

 

[Signature
Page Follows]

 

    	-10-

     

    

 

By
its signature below, each of the parties signifies its acceptance of the terms of this Agreement, in the case of the Company by its duly
authorized officer.

 

	COMPANY	RenovoRX, INC.
	 	 	 
	 	By:	/s/
    K. Angela Macfarlane
	 	 	K.
    Angela Macfarlane
	 	 	 
	 	Title:	Director
	 	 	 
	 	Date:	November
    11, 2021
	 	 	 
	EXECUTIVE	 	/s/
    Shaun R. Bagai
	 	 	 
	 	 	Shaun
    R. Bagai
	 	 	 
	 	Date:
	November 11, 2021

 

    	-11-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00336-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00336-of-00352.parquet"}]]